Immunic: Morgan Stanley reports 5.2% passive stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Immunic, Inc. (IMUX) was the subject of Morgan Stanley’s report of beneficial ownership of 704,244 shares of common stock, equal to 5.2% of the class. Morgan Stanley reported shared voting power over 702,419 shares and shared dispositive power over 704,244 shares, with zero sole voting or dispositive power. The reported figures cover certain Morgan Stanley operating units and exclude units whose ownership is disaggregated under the referenced SEC release.
Key Figures
Key Terms
beneficially owned regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.